LEHI, Utah / Nov 14, 2023 / Business Wire / Owlet, Inc. (“Owlet”) (NYSE: OWLT) today announced that it will participate in the BTIG Digital Health Forum, taking place on Monday, November 20, 2023, virtually. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to engage in a fireside chat on Monday, November 20, at 11 a.m. Eastern Time. Management will also participate in 1x1 meetings which may be requested through BTIG.
About Owlet, Inc.
Owlet was founded by a team of parents in 2012. Owlet’s mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting. Owlet’s digital parenting platform aims to give parents real-time data and insights to help parents feel calmer and more confident. Owlet believes that every parent deserves peace of mind and the opportunity to feel their well-rested best. Owlet also believes that every child deserves to live a long, happy, and healthy life, and is working to develop products to help further that belief. To learn more, visit www.owletcare.com.
| Last Trade: | US$8.86 |
| Daily Change: | 0.09 1.03 |
| Daily Volume: | 121,699 |
| Market Cap: | US$236.560M |
October 21, 2025 September 09, 2025 September 04, 2025 August 21, 2025 | |

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load